-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test is an affordable, accessible blood test that detects cancer in dogs.
Nu.Q® Vet White Paper: Detecting cancer early to give dogs and their owners a brighter tomorrow.
- Share
- Tweet
- Share on Facebook
- Share
The Nu.Q® Vet Cancer Test is a simple, non-invasive blood test that enables early detection of cancer in dogs. Designed to be part of routine wellness checks, the test identifies circulating nucleosomes linked to cancer, delivering results within minutes (in-house) or just a few days (via reference labs). With 76% sensitivity for systemic cancers and 97% specificity, it offers a powerful tool to improve outcomes, lower treatment costs, and extend quality of life.
This comprehensive white paper goes beyond the science, including real-world case studies, veterinarian interviews, and pet owner testimonials that showcase the life-changing impact of early cancer detection.
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields